Literature DB >> 12731422

[Hepatitis of unknown origin with protracted liver failure in a 48-year-old patient with significantly increased pANCA titer].

H Y Sohn1, F Krötz, S Rothenfusser, R Zachoval, S Siegert, U Löhrs, W Heldwein.   

Abstract

In spite of intense diagnostic testing, no cause for the chronically aggressive hepatitis of a 48-year old male patient was found. Evidence for an autoimmune process, however, could be derived from a high titer of pANCA. Only according to the revised criteria of the working group on autoimmune hepatitis, but not to the first version, it was possible to classify this as an autoimmune hepatitis. Despite of high-dose steroid treatment and accelerated preparation for liver transplantation the patient died of the complications of rapid liver failure. Thus, in case of unclear rapid progressive hepatitis, the revised criteria of autoimmune hepatitis should be reviewed early and with high priority and consequent high-dose steroid therapy and preparation for liver transplantation should be initiated. The prognostic impact of a high titer of pANCA in patients with autoimmune hepatitis remains to be established.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12731422     DOI: 10.1007/s00108-002-0815-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  12 in total

1.  Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.

Authors:  D S Bansi; M Bauducci; A Bergqvist; K Boberg; U Broome; R Chapman; K Fleming; R Jorgensen; K Lindor; F Rosina; E Schrumpf
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-06       Impact factor: 2.566

2.  Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.

Authors:  R H Duerr; S R Targan; C J Landers; N F LaRusso; K L Lindsay; R H Wiesner; F Shanahan
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

3.  Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis.

Authors:  D Zauli; S Ghetti; A Grassi; C Descovich; F Cassani; G Ballardini; L Muratori; F B Bianchi
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

4.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

5.  Meeting report: International Autoimmune Hepatitis Group.

Authors:  P J Johnson; I G McFarlane
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

6.  Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis.

Authors:  C S Pokorny; I D Norton; G W McCaughan; W S Selby
Journal:  J Gastroenterol Hepatol       Date:  1994 Jan-Feb       Impact factor: 4.029

7.  Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis?

Authors:  S Kaymakoglu; Y Cakaloglu; K Demir; S Türkoglu; S Badur; S Gürel; F Beşişik; U Cevikbaş; A Okten
Journal:  J Hepatol       Date:  1998-01       Impact factor: 25.083

8.  Ultrasound-detected abdominal lymphadenopathy in chronic hepatitis C: high frequency and relationship with viremia.

Authors:  F Cassani; P Valentini; M Cataleta; P Manotti; R Francesconi; F Giostra; G Ballardini; M Lenzi; D Zauli; F B Bianchi
Journal:  J Hepatol       Date:  1997-03       Impact factor: 25.083

9.  Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis.

Authors:  L Sanchez-Urdazpal; A J Czaja; B van Hoek; R A Krom; R H Wiesner
Journal:  Hepatology       Date:  1992-02       Impact factor: 17.425

10.  Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.

Authors:  A H Mulder; G Horst; E B Haagsma; P C Limburg; J H Kleibeuker; C G Kallenberg
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.